News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

French Anti-Infectives Developer Mutabilis Takes $9.6M Second Round


10/19/2005 5:08:45 PM

As hospital-acquired infections rise and the widespread use of broad-spectrum antibiotics gives birth to dangerous new pathogens, a host of biotech start-ups are focusing their research on novel approaches to target bacteria resistance.



comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES